Grant ID RP220244
Awarded On February 16, 2022
Title AI-based conversational agent for facilitating education and communication about HPV vaccination in children and adolescents
Program Academic Research
Award Mechanism Individual Investigator Research Awards for Cancer in Children and Adolescents
Institution/Organization The University of Texas Health Science Center at Houston
Principal Investigator/Program Director Licong Cui
Cancer Sites Ovary, Penis, Vagina
Contracted Amount $1,397,258
Lay Summary

Human papillomavirus (HPV) infections cause about 34,000 cases of cancers every year in the U.S. The HPV vaccine is noted to be 99% effective against the HPV virus. One predictive study reported that if the population were to have 70% coverage of HPV vaccine, at least 4 million deaths worldwide could be prevented in the next decade.

For the HPV vaccine to be effective, patients need to complete the two to three dose series for the vaccine. Currently, the completion rates for the HPV vaccine for adolescents in the United States population is 48.6%, short of the 80% uptake goal. A number of factors affect a child's receipt of HPV vaccines, including parental awareness and provider recommenda...

Read More